Search research articles
Contact Us
Filters
Showing results (91-100 of 103) with videos related to
Page
of 11
Sort By:
Journal of Neuroendocrinology
|
August 9, 2025
Controversies in NEN: An ENETS position statement on the treatment of patients with Grade 3 well-differentiated neuroendocrine tumours of the gastro-enteropancreatic tract
Mairéad G McNamara, Halfdan Sorbye, Nehara Begum, et al.
Journal of Neuroendocrinology
|
August 14, 2023
European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes
Johannes Hofland, Massimo Falconi, Emanuel Christ, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 26, 2022
The European Neuroendocrine Tumour Society registry, a tool to assess the prognosis of neuroendocrine neoplasms
Ivan Borbath, Rocio Garcia-Carbonero, Damir Bikmukhametov, et al.
The Lancet. Diabetes & Endocrinology
|
March 14, 2014
Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study
Emanuel Christ, Damian Wild, Susanne Ederer, et al.
Frontiers in Immunology
|
January 7, 2021
Co-Occurrence of ANCA-Associated Vasculitis and Sjögren's Syndrome in a Patient With Acromegaly: A Case Report and Retrospective Single-Center Review of Acromegaly Patients
Philipp S Fuchs, Jonas Lötscher, Caroline M Berkemeier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 11, 2025
Targeted β<sup>-</sup>-Particle Plus Conversion and Auger-Electron Therapy with <sup>161</sup>Tb-Labeled Somatostatin Receptor Antagonist DOTA-LM3: A Phase 0 Study
Julia G Fricke, Frida Westerbergh, Lisa McDougall, et al.
Annals of Surgical Oncology
|
November 14, 2019
Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms?
Elettra Merola, Anja Rinke, Stefano Partelli, et al.
The New England Journal of Medicine
|
August 2, 2018
A Copeptin-Based Approach in the Diagnosis of Diabetes Insipidus
Wiebke Fenske, Julie Refardt, Irina Chifu, et al.
Journal of Neuroendocrinology
|
December 14, 2023
Use and perceived utility of [<sup>18</sup> F]FDG PET/CT in neuroendocrine neoplasms: A consensus report from the European Neuroendocrine Tumor Society (ENETS) Advisory Board Meeting 2022
Valentina Ambrosini, Martyn Caplin, Justo P Castaño, et al.
Journal of Neuroendocrinology
|
December 9, 2024
Challenges in developing response evaluation criteria for peptide receptor radionuclide therapy: A consensus report from the European Neuroendocrine Tumor Society Advisory Board Meeting 2022 and the ENETS Theranostics Task Force
Vikas Prasad, Anna Koumarianou, Timm Denecke, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 103) with videos related to
Sort By:
Page
of 11
Journal of Neuroendocrinology
|
August 9, 2025
Controversies in NEN: An ENETS position statement on the treatment of patients with Grade 3 well-differentiated neuroendocrine tumours of the gastro-enteropancreatic tract
Mairéad G McNamara, Halfdan Sorbye, Nehara Begum, et al.
Journal of Neuroendocrinology
|
August 14, 2023
European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes
Johannes Hofland, Massimo Falconi, Emanuel Christ, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 26, 2022
The European Neuroendocrine Tumour Society registry, a tool to assess the prognosis of neuroendocrine neoplasms
Ivan Borbath, Rocio Garcia-Carbonero, Damir Bikmukhametov, et al.
The Lancet. Diabetes & Endocrinology
|
March 14, 2014
Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study
Emanuel Christ, Damian Wild, Susanne Ederer, et al.
Frontiers in Immunology
|
January 7, 2021
Co-Occurrence of ANCA-Associated Vasculitis and Sjögren's Syndrome in a Patient With Acromegaly: A Case Report and Retrospective Single-Center Review of Acromegaly Patients
Philipp S Fuchs, Jonas Lötscher, Caroline M Berkemeier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 11, 2025
Targeted β<sup>-</sup>-Particle Plus Conversion and Auger-Electron Therapy with <sup>161</sup>Tb-Labeled Somatostatin Receptor Antagonist DOTA-LM3: A Phase 0 Study
Julia G Fricke, Frida Westerbergh, Lisa McDougall, et al.
Annals of Surgical Oncology
|
November 14, 2019
Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms?
Elettra Merola, Anja Rinke, Stefano Partelli, et al.
The New England Journal of Medicine
|
August 2, 2018
A Copeptin-Based Approach in the Diagnosis of Diabetes Insipidus
Wiebke Fenske, Julie Refardt, Irina Chifu, et al.
Journal of Neuroendocrinology
|
December 14, 2023
Use and perceived utility of [<sup>18</sup> F]FDG PET/CT in neuroendocrine neoplasms: A consensus report from the European Neuroendocrine Tumor Society (ENETS) Advisory Board Meeting 2022
Valentina Ambrosini, Martyn Caplin, Justo P Castaño, et al.
Journal of Neuroendocrinology
|
December 9, 2024
Challenges in developing response evaluation criteria for peptide receptor radionuclide therapy: A consensus report from the European Neuroendocrine Tumor Society Advisory Board Meeting 2022 and the ENETS Theranostics Task Force
Vikas Prasad, Anna Koumarianou, Timm Denecke, et al.
Page
of 11